November 12, 2024
- Moma update - December 9, 2024
- Bionical Emas sells EMAS Pharma to Kester Capital following strategic review - December 9, 2024
- Citryll Raises EUR 85 Million Series B to Advance Novel NET-Targeting Therapy for Immune-Mediated Inflammatory Disorders - December 9, 2024